F.D.A. Panel Splits on Whether to Approve New Diabetes Drug by KATIE THOMAS

By KATIE THOMAS

The advisory committee voted 8-8 on approving the drug, to be called Zynquista, which would be the first oral medication for people with Type 1 diabetes.

Published: January 16, 2019 at 07:00PM

from NYT Health https://nyti.ms/2FGsGur
via IFTTT

from WordPress http://bit.ly/2U3rLZ9
via IFTTT